Search 33,000+ CME courses
Back

Catalyst Medical Education, LLC, AKH Inc., Advancing Knowledge in Healthcare

  • Anemia, Sickle Cell
  • Genetic Therapy
  • Vaso-Occlusive Crises

Addressing Unmet Needs in Sickle Cell Disease: Evaluating the Potential for Emerging Treatments to Achieve Positive Patient Outcomes

Sickle cell disease (SCD) remains a complex, multisystem disorder with persistent gaps in care despite advances that have extended life expectancy. This interactive CME program brings together leading hematology experts and patient voices to explore how clinicians can go beyond managing vaso-occlusive crises to address the full burden of SCD including chronic anemia, organ damage, and quality-of-life challenges. Through expert-led presentations, dynamic roundtable discussions, and a patient interview, participants will gain insight into the evolving SCD landscape, from current standards of care to the promise and limitations of gene therapy. The program also highlights emerging investigational strategies such as pyruvate kinase activation, fetal hemoglobin induction, and novel polymerization inhibitors that may redefine treatment goals and improve outcomes for individuals living with SCD.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • Commercial Support
  • Released
    Oct 31, 2025
  • Last day to claim credit
    Nov 1, 2026 3 weeks left

Related courses

See all

Other providers’ courses on the same topic

More from AKH Inc., Advancing Knowledge in Healthcare

See all

This provider’s courses closest to this one